Same-day administration of verteporfin and ranibizumab 0.5 mg in patients with choroidal neovascularisation due to age-related macular degeneration (Q46388883)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Same-day administration of verteporfin and ranibizumab 0.5 mg in patients with choroidal neovascularisation due to age-related macular degeneration |
scientific article |
Statements
1 reference
Same-day administration of verteporfin and ranibizumab 0.5 mg in patients with choroidal neovascularisation due to age-related macular degeneration (English)
1 reference
U Schmidt-Erfurth
1 reference
S Wolf
1 reference
PROTECT Study Group
1 reference
4 September 2008
1 reference
92
1 reference
12
1 reference
1628-1635
1 reference